Just a few years ago, the idea of at-home testing was practically antithetical to Caesar Djavaherian’s mission. The clinician and founder was laser-focused on serving people in person with his network of urgent care clinics. Fast forward to the spring of 2020, and his company — fresh off the heels of a merger with Carbon Health — was dashing to offer one of the first at-home test kits for Covid-19.
Home diagnostics have long been considered a kind of holy grail in telehealth: While a majority of virtual care can now be conducted remotely, the process of identifying a condition typically requires a physical visit. But a recent burst of activity in the sector — fueled by the pandemic and its need for rapid, remote tests — offers the potential to solve one of the industry’s thorniest last-mile problems.
About the Author Reprints
